Memorial Sloan Kettering Cancer Center
New York, United States
Ghassan Abou-Alfa is an Attending Physician at Memorial Sloan Kettering Cancer Center (MSK) and Professor of Medicine at Weill Medical School at Cornell University. Professor Abou-Alfa specializes in in the treatment of gastrointestinal malignancies and in particular, hepatocellular carcinoma (HCC), intrahepatic and extrahepatic cholangiocarcinoma (IHC), gallbladder cancer (GB), and fibrolamellar carcinoma (FLC). Professor Abou-Alfa is a member of the International Affairs Committee of the American Society of Clinical Oncology (ASCO) and serves as member of its Steering Committee. Professor Abou-Alfa is the immediate past-President for the International Society of Gastrointestinal Oncology (ISGIO). Professor Abou-Alfa majored in biology, earned his medical degree, and now serves as a trustee on the Board of Trustees of his alma mater the American University in Beirut (AUB). Professor Abou-Alfa completed his postdoctoral training in internal medicine, medical oncology, and hematology at Yale University, is completing his JD at Fordham University, and already received his MBA from Columbia University.
Professor Abou-Alfa envisions the universal quest for health, embodied by physicians upholding humanistic ideals, supersedes geopolitics among the world’s people. Recognizing germline alterations as an endless opportunity to explore cancer related environmental and other genetic risk factors of varied populations and regions, Professor Abou-Alfa is co-leading with Professor Larry Norton a global effort to study humanity cancer germline convergence and divergence cancer predispositions worldwide. Professor Abou-Alfa strongly advocates for greater awareness of cancer’s global impact; and continues to lead several international educational and research efforts with different institutions worldwide. Professor Abou-Alfa spearheaded many projects worldwide.
Thursday, June 30, 2022
08:00 – 08:45